🇺🇸 FDA
Pipeline program

Sintilimab Combined with Platinum-containing Chemotherapy

MT-003

Phase 2 small_molecule active

Quick answer

Sintilimab Combined with Platinum-containing Chemotherapy for Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Non-small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials